Abstract
DEMOGRAPHIC & CLINICAL PROFILE OF HOSPITALIZED AND NON-HOSPITALIZED COVID-19 PATIENTS IN BANGLADESH
Md. Al-Amin Hossen, Sadia Islam, Md. Ashiqur Rahman, Md. Matiur Rahman, Md Mehedi Hasan, Md. Farhad Hossain Jony, Marzan Islam Lubaba and Arifa Akram*
ABSTRACT
Introduction: The COVID-19 pandemic emerged as a major public health emergency affecting the healthcare services all over the world. This study highlights demographic and clinical experience in hospitalized and non-hospitalized covid-19 patients in Bangladesh. Methodology: The study was conducted under Molecular Laboratory of Novus CRSL Dhaka between April 2021 September 2021. The diagnosis of SARS-CoV-2 infection was confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) on oropharyngeal swab and/or nasopharyngeal swabs in our laboratory. By contacting them with their contact number from the database then we collected their demographic, clinical and laboratory parameters. Results: Data of 150 both non-hospitalized and hospitalized patients with COVID-19 were recorded and analyzed. In non-hospitalized patients, the mean age of the patients was 44.42 ± 14.20 year with 84 (80.8%) male and 20 (19.2%) female. Comorbidities were present of which hypertension 40 (38.5%), diabetes 34 (32.7%), hypothyroidism 16 (15.4%) and others. A significant proportion of patients had symptomatic such as fever 96 (92.3%), dry cough 92 (88.5%), loss of taste 50 (48.07%), loss of smell 53 (50.96%) was the most common and normal laboratory parameters. Majority of the patients were managed with supportive treatment with paracetamol 40 (38.46%), antihistamine 80 (76.9%), oral vitamin-c 87 (83.65%), and antibiotics 70 (67.30%). It took an average of 12-14 days for them to become negative. And hospitalized patients, of whom 37 (71.73%) were males and 13 (28.26%) were female. Overall mean age was 45.12±13.80 years. Maximum cases (58.69%) were from age group of 20-40 year. 19 (41.30%) were smoker. They have some kind of comorbidities present like diabetes mellitus 21 (45.65%), hypertension 26 (56.52%), hyperlipidemia 8 (17.39%), hypothyroidism 2 (4.34%), coronary heart disease 10 (21.73%), chronic respiratory disease 1 (2.17%), severe disease 2 (4.34%). In addition, they have taken some medicine as per the doctors advise such as paracetamol 21 (45.65%), antihistamine 29 (63.04), oral vitamin c 32 (69.56%), antibiotics 27 (58.69%), antifungal 21 (45.6%) and oxygen therapy 7 (15.21%). Some changed laboratory parameters were observed. Conclusion: We concluded that there is no significant changes or abnormalities in non-hospitalized patients clinical and laboratory parameter reports but significant changes in hospitalized patient’s laboratory parameters. There is a warning for them which is post covid-19 fatigue.
[Full Text Article] [Download Certificate]WJPLS CITATION 
All | Since 2020 | |
Citation | 590 | 424 |
h-index | 12 | 10 |
i10-index | 17 | 14 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here